Luoxin Pharmaceuticals Group Stock Co Ltd (002793) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.059x

Based on the latest financial reports, Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a cash flow conversion efficiency ratio of 0.059x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥90.75 Million ≈ $13.28 Million USD) by net assets (CN¥1.53 Billion ≈ $223.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002793 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Luoxin Pharmaceuticals Group Stock Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Luoxin Pharmaceuticals Group Stock Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Luoxin Pharmaceuticals Group Stock Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Luoxin Pharmaceuticals Group Stock Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Solid Power Inc NASDAQ:SLDP	-0.036x
Beijing Chunlizhengda Medical Instruments Co Ltd SHG:688236	0.011x
Sinoma Energy Conservation Ltd SHG:603126	-0.039x
Castle Biosciences Inc NASDAQ:CSTL	-0.048x
Sarkuysan Elektrolitik Bakir Sanayi ve Ticaret AS IS:SARKY	-0.017x
PPC Ltd JSE:PPC	0.136x
GuangDong GenSho Logistics Co SHG:603813	-0.033x
China Steel Chemical Corp TW:1723	0.022x

Annual Cash Flow Conversion Efficiency for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Luoxin Pharmaceuticals Group Stock Co Lt.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.24 Billion ≈ $180.82 Million	CN¥253.07 Million ≈ $37.03 Million	0.205x	+289.35%
2024-12-31	CN¥1.46 Billion ≈ $213.56 Million	CN¥-157.85 Million ≈ $-23.10 Million	-0.108x	-150.33%
2023-12-31	CN¥2.57 Billion ≈ $376.42 Million	CN¥552.79 Million ≈ $80.89 Million	0.215x	+175.66%
2022-12-31	CN¥3.31 Billion ≈ $483.84 Million	CN¥-939.13 Million ≈ $-137.42 Million	-0.284x	-1215.03%
2021-12-31	CN¥4.74 Billion ≈ $692.99 Million	CN¥120.63 Million ≈ $17.65 Million	0.025x	+442.04%
2020-12-31	CN¥4.35 Billion ≈ $636.59 Million	CN¥-32.40 Million ≈ $-4.74 Million	-0.007x	-125.36%
2019-12-31	CN¥3.96 Billion ≈ $579.73 Million	CN¥116.33 Million ≈ $17.02 Million	0.029x	-76.59%
2018-12-31	CN¥909.89 Million ≈ $133.14 Million	CN¥114.12 Million ≈ $16.70 Million	0.125x	-7.52%
2017-12-31	CN¥754.19 Million ≈ $110.36 Million	CN¥102.27 Million ≈ $14.97 Million	0.136x	+30.19%
2016-12-31	CN¥698.33 Million ≈ $102.19 Million	CN¥72.74 Million ≈ $10.64 Million	0.104x	-39.16%
2015-12-31	CN¥339.50 Million ≈ $49.68 Million	CN¥58.12 Million ≈ $8.51 Million	0.171x	+29.11%
2014-12-31	CN¥315.46 Million ≈ $46.16 Million	CN¥41.83 Million ≈ $6.12 Million	0.133x	-48.50%
2013-12-31	CN¥251.50 Million ≈ $36.80 Million	CN¥64.75 Million ≈ $9.48 Million	0.257x	+58.84%
2012-12-31	CN¥205.54 Million ≈ $30.08 Million	CN¥33.31 Million ≈ $4.88 Million	0.162x	-47.10%
2011-12-31	CN¥151.87 Million ≈ $22.22 Million	CN¥46.53 Million ≈ $6.81 Million	0.306x	--

About Luoxin Pharmaceuticals Group Stock Co Ltd

SHE:002793 China Drug Manufacturers - Specialty & Generic

Market Cap

$636.59 Million

CN¥4.35 Billion CNY

Market Cap Rank

#11193 Global

#3177 in China

Share Price

CN¥4.00

Change (1 day)

+0.50%

52-Week Range

CN¥3.98 - CN¥6.50

All Time High

CN¥25.07